Cyclosporine Ophthalmic

Major

Cyclosporine Ophthalmic Digoxin Cardoxin® Increased digoxin exposure and an increased risk of digoxin toxicity Details Cyclosporine Ophthalmic Dihydrocodeine Increased dihydrocodeine exposure and an increased risk of respiratory depression Details Cyclosporine Ophthalmic Diltiazem Cardizem Increased cycloSPORINE exposure, an increased risk of cycloSPORINE toxicity (renal dysfunction, cholestasis, paresthesias) and an... Details Cyclosporine Ophthalmic Dipyrone An increased risk of cycloSPORINE nephrotoxicity Details Cyclosporine Ophthalmic Domperidone Increased domperidone exposure and an increased risk of QT prolongation Details Cyclosporine Ophthalmic Donepezil Adlarity Reduced seizure threshold Details Cyclosporine Ophthalmic Doxorubicin Adriamycin Increased DOXOrubicin exposure and an increased risk of DOXOrubicin-related adverse reactions Details Cyclosporine Ophthalmic Doxorubicin Hydrochloride Liposome Increased DOXOrubicin exposure and an increased risk of DOXOrubicin-related adverse reactions Details Cyclosporine Ophthalmic Drospirenone Increased cycloSPORINE exposure and an increased risk of cycloSPORINE toxicity (renal dysfunction, cholestasis, paresthesias) Details Cyclosporine Ophthalmic Droxicam An increased risk of cycloSPORINE nephrotoxicity Details Cyclosporine Ophthalmic Duvelisib Copiktra Increased cycloSPORINE exposure Details Cyclosporine Ophthalmic Ebola Zaire Vaccine, Live An inadequate immunological response to the vaccine, increased risk of disseminated infection with live vaccines and reduced effic... Details Cyclosporine Ophthalmic Edoxaban Savaysa Increased edoxaban exposure Details Cyclosporine Ophthalmic Efavirenz Reduced cycloSPORINE exposure Details Cyclosporine Ophthalmic Elacestrant Orserdu Increased elacestrant/cycloSPORINE exposure and an increased risk of elacestrant/cycloSPORINE-related adverse effects Details Cyclosporine Ophthalmic Elexacaftor Increased elexacaftor exposure Details Cyclosporine Ophthalmic Elinzanetant Lynkuet Increased CYP3A4 substrate with NTI exposure and an increased CYP3A4 substrate with NTI-related adverse reactions Details Cyclosporine Ophthalmic Eluxadoline Viberzi Increased eluxadoline and/or cyclosporine exposure Details Cyclosporine Ophthalmic Enalaprilat Acute renal dysfunction and an increased risk of hyperkalemia Details Cyclosporine Ophthalmic Enalapril Maleate Acute renal dysfunction and an increased risk of hyperkalemia Details Cyclosporine Ophthalmic Enasidenib Idhifa Reduced CYP3A substrate exposure and reduced efficacy of CYP3A substrate Details Cyclosporine Ophthalmic Encorafenib Braftovi Reduced CYP3A4 substrate exposure and reduced efficacy of CYP3A4 substrate Details Cyclosporine Ophthalmic Ensartinib Increased ensartinib exposure Details Cyclosporine Ophthalmic Entrectinib Rozlytrek Increased cycloSPORINE exposure Details Cyclosporine Ophthalmic Enzalutamide Xtandi Reduced cycloSPORINE exposure, reduced efficacy of cycloSPORINE and an increased enzalutamide exposure Details Cyclosporine Ophthalmic Eplerenone Inspra An increased risk of hyperkalemia Details Cyclosporine Ophthalmic Eprosartan Teveten® An increased risk of hyperkalemia Details Cyclosporine Ophthalmic Erdafitinib Balversa Increased P-gp substrate exposure and an increased risk of P-gp substrate-related adverse effects Details Cyclosporine Ophthalmic Erythromycin Erythrocin Stearate Increased cycloSPORINE exposure and an increased risk of cycloSPORINE toxicity (renal dysfunction, cholestasis, paresthesias) Details Cyclosporine Ophthalmic Eslicarbazepine Acetate Aptiom Reduced cycloSPORINE exposure Details Cyclosporine Ophthalmic Estetrol Increased cycloSPORINE exposure and an increased risk of cycloSPORINE toxicity (renal dysfunction, cholestasis, paresthesias) Details Cyclosporine Ophthalmic Estradiol Delestrogen Increased cycloSPORINE exposure and an increased risk of cycloSPORINE toxicity (renal dysfunction, cholestasis, paresthesias) Details Cyclosporine Ophthalmic Ethinyl Estradiol Increased cycloSPORINE exposure and an increased risk of cycloSPORINE toxicity (renal dysfunction, cholestasis, paresthesias) Details Cyclosporine Ophthalmic Ethynodiol Increased cycloSPORINE exposure and an increased risk of cycloSPORINE toxicity (renal dysfunction, cholestasis, paresthesias) Details Cyclosporine Ophthalmic Etodolac Lodine An increased risk of cycloSPORINE nephrotoxicity Details Cyclosporine Ophthalmic Etofenamate An increased risk of cycloSPORINE nephrotoxicity Details Cyclosporine Ophthalmic Etoposide Avopef Dramatic increases in etoposide systemic exposure and leukopenia Details Cyclosporine Ophthalmic Etoricoxib An increased risk of cycloSPORINE nephrotoxicity Details Cyclosporine Ophthalmic Etravirine Intelence Reduced cycloSPORINE exposure Details Cyclosporine Ophthalmic Fedratinib Inrebic Increased CYP3A4 substrate exposure Details